Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Iduronic Acid-Containing Glycosaminoglycans on Target Cells Are Required for Efficient Respiratory Syncytial Virus Infection
2000
Heparan sulfate proteoglycans and cancer
2001
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
The prognostic value of positron emission tomography in non-small cell lung cancer: Analysis of 266 cases
2006
Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone)
2008
Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging
2005 StandoutNobel
Prognostic Factors in Non-small Cell Lung Cancer
2002
Molecular imaging in drug development
2008 Standout
Le traitement chirurgical du cancer bronchique non à petites cellules
2004
PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma
2001
Establishing the Diagnosis of Lung Cancer
2013 Standout
Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions
2000
Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease
2001
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer
2006
FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?
1998
Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery
1997
Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer
2002
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project
2008
Mediastinal Lymph Node Sampling Following Positron Emission Tomography With Fluorodeoxyglucose Imaging in Lung Cancer Staging
2001
The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer
2000
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Diffuse progressive pulmonary interstitial and intra-alveolar cholesterol granulomas in childhood
1996 StandoutNobel
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
FDG–PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology
2002
Initial Diagnosis of Lung Cancer
2007
Head and neck cancer
2008 Standout
Selective Reporting Biases in Cancer Prognostic Factor Studies
2005
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project
2010
Gold nanoparticles as novel agents for cancer therapy
2012
Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy
2002
Esophageal Cancer
2003 Standout
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
1998
A multigenic program mediating breast cancer metastasis to bone
2003 Standout
Syndecan-1 expression in locally invasive and metastatic prostate cancer
2004
Machine Learning methods for Quantitative Radiomic Biomarkers
2015 Standout
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
2010
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
2000
Extracellular matrix structure
2015 Standout
F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma
2001
F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer*1
1999
Regulation of cancer cell metabolism
2011 Standout
F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy
2005
Overexpression of Glut‐1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma
2003
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing 18F-FDG PET/CT SUV quantifica
2013
An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer
2002
Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review
2001
Cost-Minimization Analysis of Alternative Diagnostic Approaches in a Modeled Patient With Non-Small Cell Lung Cancer and Subcarinal Lymphadenopathy
2002
Development and External Validation of Prognostic Model for 2-Year Survival of Non–Small-Cell Lung Cancer Patients Treated With Chemoradiotherapy
2008
Comparative Efficacy of Positron Emission Tomography With Fluorodeoxyglucose in Evaluation of Small (<1 cm), Intermediate (1 to 3 cm), and Large (>3 cm) Lymph Node Lesions
2000
GlcNAc 2-Epimerase Can Serve a Catabolic Role in Sialic Acid Metabolism
2003 StandoutNobel
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Role of fiberscopic transbronchial needle aspiration in the staging of N2 disease due to non–small cell lung cancer
2002
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
2003
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung Cancer
1997
CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers
2001
Tomographic imaging using the nonlinear response of magnetic particles
2005 StandoutNature
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: Relationship to therapeutic response—a preliminary report
2003
Accuracy and Clinical Impact of Mediastinal Lymph Node Staging with FDG–PET Imaging in Potentially Resectable Lung Cancer
2000
Positron-emission tomography as a prognostic tool for early-stage lung cancer
2006
Methods for Staging Non-small Cell Lung Cancer
2013
Coexisting Endogenous Lipoid Pneumonia, Cholesterol Granulomas, And Pulmonary Alveolar Proteinosis in a pediatric Population: A Clinical, Radiographic, and Pathologic Correlation
1992
The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer
2007
Staging of non-small cell lung cancer: consensus, controversies and challenges
2001
Clinical imaging of cancer metastasis
2000
Value of positron emission tomography for lung cancer staging
2002
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Non-Small Cell Lung Cancer: FDG PET for Nodal Staging in Patients with Stage I Disease
2000
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
2002
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Special Treatment Issues in Non-small Cell Lung Cancer
2013
Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa–N2 non-small-cell lung cancer: A prospective pilot study
1998
Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?
2002
Diagnosis and staging of bronchogenic carcinoma by transtracheal and transbronchial needle aspiration
1995
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Positron Emission Tomography Scanning: Current and Future Applications
2002
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Intensity of18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s Lymphoma
2005
18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
2002
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Implications of Microscopic Satellites of the Primary and Extracapsular Lymph Node Spread in Patients With High-Risk Melanoma: Pathologic Corollary of Eastern Cooperative Oncology Group Trial E1690
2002
A Chondroitin Sulfate Proteoglycan on Human Neutrophils Specifically Binds Platelet Factor 4 and Is Involved in Cell Activation
1998
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer
2002
Evaluation of 18F‐2‐deoxy‐2‐fluoro‐d ‐glucose Positron Emission Tomography for Gastric Cancer
2004
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery
2006
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
PET-based treatment planning in radiotherapy: a new standard?
2007
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
18F-FDG PET/CT Imaging In Oncology
2011
Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer
2005
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Kinetic Analysis of NodST Sulfotransferase Using an Electrospray Ionization Mass Spectrometry Assay
2002 StandoutNobel
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma
2000
Prognostic Value of Thoracic FDG PET Imaging After Treatment for Non-Small Cell Lung Cancer
2000
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.
2002
Cost-Minimization Analysis of Alternative Diagnostic Approaches in a Modeled Patient With Non-Small Cell Lung Cancer and Subcarinal Lymphadenopathy
2002
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Georges Deneffe being referenced
Heparan sulfate proteoglycan expression in human lung-cancer cells
1997
Histopathologic Validation of Lymph Node Staging With FDG-PET Scan in Cancer of the Esophagus and Gastroesophageal Junction
2000
Transcarinal needle aspiration biopsy in the staging of lung cancer
1994
Practical approach to patients presenting with multiple synchronous suspect lung lesions
2001
Incentive spirometry does not enhance recovery after thoracic surgery
2000
Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature
1998
Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
1998
Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases
1997
Amiodarone and the Development of ARDS After Lung Surgery
1994
Cervical mediastinoscopy and anterior mediastinotomy in patients with lung cancer and radiologically normal mediastinum.
1983
Bronchioloalveolar carcinoma: long-term survival of 23 resected patients.
1996
Pulmonary phospholipid accumulation distal to an obstructed bronchus. A morphologic study.
1989
Five-year survival in resected T3/N2 lung cancer.
1989
Heparan sulfate proteoglycan expression in human lung‐cancer cells
1997
Prognostic Importance of the Standardized Uptake Value on 18F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 Cases
1999
Sleeve Lobectomy for Non-Small Cell Lung Cancer
2003